Johnson & Johnson Announced Plans To Buy Synthes Following M

April 27, 2011

Johnson & Johnson (NYSE:JNJ) announced plans to buy Synthes Inc. in a $21.3 billion deal aimed at further expanding the company's orthopedic-device business.The final price of the cash-and-stock deal will not be set until 10 days before the closing, which may not be for a year, according to the Wall Street Journal.The deal was approved by both companies' boards and is expected to close during the first half of 2012.Synthes shareholders will receive 55.65 Swiss francs in cash and 103.35 francs in J&J common stock for each Synthes share.